HLTF and SHPRH are regarded as candidate tumor suppressor genes, because loss of function or dysregulation has been linked to cancer development [20,21,22], and HLTF is often epigenetically silenced by promotor hypermethylation in colon cancers (~40%) [23]. The gene discussed is HLTF; the disease is cancer.